Larissa leads the way in treating human parainfluenza virus
Pre-clinical trials are being planned on a treatment for human parainfluenza virus discovered by the Institute for Glycomics. This treatment...
Pre-clinical trials are being planned on a treatment for human parainfluenza virus discovered by the Institute for Glycomics. This treatment...
Researchers develop drug target to tackle multi-drug resistant lung bacterium.
Nine new Griffith-led ARC Discovery Projects awarded $3,622,738.
A drug normally used to prevent tissue rejection following organ transplants could be repurposed to help treat human metapneumovirus (HMPV) infection in children.
Four teams of expert scientists from Griffith University’s Institute for Glycomics are targeting the virus SARS-CoV-2 to discover new vaccines...
Griffith University research into fighting diseases of global impact are set to benefit from the latest National Health and Medical...
Griffith University's Institute for Glycomics has announced its 2016 research excellence awards.
Griffith’s Institute for Glycomics have made a promising discovery in the treatment and prevention of human parainfluenza virus.
Barbara Hadley has been a professional snooker player, a private investigator and a chief toilet cleaner in the Greek Islands....
Gold Coast research has made a giant leap forward in understanding one of the most common causes of respiratory infections worldwide.